227 related articles for article (PubMed ID: 27482630)
1. The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain.
Slosky LM; BassiriRad NM; Symons AM; Thompson M; Doyle T; Forte BL; Staatz WD; Bui L; Neumann WL; Mantyh PW; Salvemini D; Largent-Milnes TM; Vanderah TW
Pain; 2016 Nov; 157(11):2605-2616. PubMed ID: 27482630
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of breast cancer-cell glutamate release with sulfasalazine limits cancer-induced bone pain.
Ungard RG; Seidlitz EP; Singh G
Pain; 2014 Jan; 155(1):28-36. PubMed ID: 23999057
[TBL] [Abstract][Full Text] [Related]
3. xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain.
Ungard RG; Linher-Melville K; Nashed MG; Sharma M; Wen J; Singh G
Mol Pain; 2019; 15():1744806918822185. PubMed ID: 30799686
[TBL] [Abstract][Full Text] [Related]
4. Functional effects of TrkA inhibition on system x
Miladinovic T; Ungard RG; Linher-Melville K; Popovic S; Singh G
Mol Pain; 2018; 14():1744806918776467. PubMed ID: 29761734
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting STAT3 in a murine model of human breast cancer-induced bone pain delays the onset of nociception.
Linher-Melville K; Sharma M; Nakhla P; Kum E; Ungard R; Park J; Rosa D; Gunning P; Singh G
Mol Pain; 2019; 15():1744806918823477. PubMed ID: 30799695
[TBL] [Abstract][Full Text] [Related]
6. The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.
Guan J; Lo M; Dockery P; Mahon S; Karp CM; Buckley AR; Lam S; Gout PW; Wang YZ
Cancer Chemother Pharmacol; 2009 Aug; 64(3):463-72. PubMed ID: 19104813
[TBL] [Abstract][Full Text] [Related]
7. High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells.
Thomas AG; Sattler R; Tendyke K; Loiacono KA; Hansen H; Sahni V; Hashizume Y; Rojas C; Slusher BS
PLoS One; 2015; 10(8):e0127785. PubMed ID: 26252954
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain.
Forte BL; Slosky LM; Zhang H; Arnold MR; Staatz WD; Hay M; Largent-Milnes TM; Vanderah TW
Pain; 2016 Dec; 157(12):2709-2721. PubMed ID: 27541850
[TBL] [Abstract][Full Text] [Related]
9. Identification of capsazepine as a novel inhibitor of system x
Fazzari J; Balenko MD; Zacal N; Singh G
J Pain Res; 2017; 10():915-925. PubMed ID: 28458574
[TBL] [Abstract][Full Text] [Related]
10. Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation.
Grenald SA; Doyle TM; Zhang H; Slosky LM; Chen Z; Largent-Milnes TM; Spiegel S; Vanderah TW; Salvemini D
Pain; 2017 Sep; 158(9):1733-1742. PubMed ID: 28570482
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated Glutamate Transporter SLC1A1 Propels Cystine Uptake via Xc
Guo W; Li K; Sun B; Xu D; Tong L; Yin H; Liao Y; Song H; Wang T; Jing B; Hu M; Liu S; Kuang Y; Ling J; Li Q; Wu Y; Wang Q; Yao F; Zhou BP; Lin SH; Deng J
Cancer Res; 2021 Feb; 81(3):552-566. PubMed ID: 33229341
[TBL] [Abstract][Full Text] [Related]
12. Sulfasalazine attenuates ACL transection and medial menisectomy-induced cartilage destruction by inhibition of cystine/glutamate antiporter.
Tsai WY; Tsai RY; Liu CC; Wu JL; Wong CS
J Orthop Res; 2016 Apr; 34(4):650-7. PubMed ID: 26466556
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain.
Fazzari J; Lin H; Murphy C; Ungard R; Singh G
Sci Rep; 2015 Feb; 5():8380. PubMed ID: 25670024
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte activation in the periaqueductal gray promotes descending facilitation to cancer-induced bone pain through the JNK MAPK signaling pathway.
Ni HD; Xu LS; Wang Y; Li H; An K; Liu M; Liu Q; Deng H; He Q; Huang B; Fang J; Yao M
Mol Pain; 2019; 15():1744806919831909. PubMed ID: 30700204
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic potential of GABA in neuron-glia interactions of cancer-induced bone pain.
Ge MM; Chen SP; Zhou YQ; Li Z; Tian XB; Gao F; Manyande A; Tian YK; Yang H
Eur J Pharmacol; 2019 Sep; 858():172475. PubMed ID: 31228456
[TBL] [Abstract][Full Text] [Related]
16. Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells.
Linher-Melville K; Haftchenary S; Gunning P; Singh G
Mol Cell Biochem; 2015 Jul; 405(1-2):205-21. PubMed ID: 25896132
[TBL] [Abstract][Full Text] [Related]
17. Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment.
Hung CC; Lin CH; Lane HY
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575878
[TBL] [Abstract][Full Text] [Related]
18. Spinal SET7/9 may contribute to the maintenance of cancer-induced bone pain in mice.
Hang LH; Xu ZK; Wei SY; Shu WW; Luo H; Chen J
Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1001-1007. PubMed ID: 28557056
[TBL] [Abstract][Full Text] [Related]
19. System X
Nehser M; Dark J; Schweitzer D; Campbell M; Zwicker J; Hitt DM; Little H; Diaz-Correa A; Holley DC; Patel SA; Thompson CM; Bridges RJ
Neurochem Res; 2020 Jun; 45(6):1375-1386. PubMed ID: 31754956
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress and cancer pain.
Ungard RG; Seidlitz EP; Singh G
Can J Physiol Pharmacol; 2013 Jan; 91(1):31-7. PubMed ID: 23368277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
